Top Two Challenges for Market Access Teams in 2021 Are Pricing Pressures and Evidence Generation

Trinity Life Sciences, a leader in global life sciences solutions, is sharing findings from its latest TGaS Landscape report entitled, “Market Access Trends and Consideration for 2021: A Biopharma Perspective.” The report, based on in-depth interviews with Market Access leaders from pre-commercial and commercial biopharma companies, finds that the top two challenges for market access teams in 2021 are pricing pressures and evidence generation.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210224005190/en/

“Our research continues to show that demand for value demonstration from payers is only increasing. In response, Trinity has continually expanded its capabilities to match this need,” said Eric Matckie, President of Value & Access at Trinity. “In addition to our strategic pricing, market access, reimbursement, and contracting practice (SPARC), we have made significant investments in our Health Economics and Outcomes Research (HEOR) and evidence generation Center of Excellence to support the value narrative.” (Photo: Business Wire)

“Pricing pressures continue to increase for treatments that have limited competition as well as those that are in more competitive environments,” said Rebecca Villari, VP, Market Access and Reimbursement. “Generating evidence that supports the value story is a strategic imperative for market access teams.”

The findings reflect much of the demand that Trinity has seen from clients in the past year.

“Our research continues to show that demand for value demonstration from payers is only increasing. In response, Trinity has continually expanded its capabilities to match this need,” said Eric Matckie, President of Value & Access at Trinity. “In addition to our strategic pricing, market access, reimbursement, and contracting practice (SPARC), we have made significant investments in our Health Economics and Outcomes Research (HEOR) and evidence generation Center of Excellence to support the value narrative.”

Besides key issues and trends, the report also covers:

• Customer Engagement
• HEOR
• Patient Support Services
• Patient Advocacy
• Creating Organizational Efficiencies

With a roster of large, emerging and precommercial life sciences companies, TGaS Advisors, a division of Trinity, provides robust comparative intelligence and collaborative network membership services.

Media interested in receiving a copy of the report should contact Elizabeth Marshall at [email protected].

About Trinity Life Sciences

Trinity Life Sciences is a trusted strategic partner, providing evidence-based solutions for the life sciences. With over 20 years of experience, Trinity is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools, and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210224005190/en/